N.V. Rajeshkumar
- Oncology top 0.5%
- Pancreatic and Hepatic Oncology Research 27
- Cancer Cells and Metastasis 7
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 9
- Cancer, Hypoxia, and Metabolism 5
- Biotechnology top 2%
- Cancer Research and Treatments 3
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 5
- RNA modifications and cancer 4
- DNA Repair Mechanisms 3
- Immunology top 10%
- Co-authors
- Manuel HidalgoAnirban MaitraDaniel A. LaheruDaniel D. Von HoffShinichi YabuuchiElizabeth De OliveiraAntonio JimenoBelén Rubio‐Viqueira
- Cited by
- OncologyCancer ResearchBiotechnology
- Journals
- Molecular Cancer Therapeutics (8 papers)Clinical Cancer Research (6 papers)British Journal of Cancer (3 papers)
- Partner nations
- United StatesSpainJapan
In The Last Decade
N.V. Rajeshkumar
43 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 2.8k
- Cancer Research 1.3k
- Biotechnology 289
- Molecular Biology 1.9k
- Immunology 398
Countries citing papers authored by N.V. Rajeshkumar
This map shows the geographic impact of N.V. Rajeshkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N.V. Rajeshkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N.V. Rajeshkumar more than expected).
Fields of papers citing papers by N.V. Rajeshkumar
This network shows the impact of papers produced by N.V. Rajeshkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N.V. Rajeshkumar. The network helps show where N.V. Rajeshkumar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside N.V. Rajeshkumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2022 | 15 | |
| 3 | 2017 | 119 | |
| 4 | 2017 | 74 | |
| 5 | 2015 | 119 | |
| 6 | Autophagy Is Critical for Pancreatic Tumor Growth and Progression in Tumors with p53 Alterationsbreakdown → | 2014 | 384 |
| 7 | 2014 | 51 | |
| 8 | 2013 | 113 | |
| 9 | 2012 | 72 | |
| 10 | 2012 | 85 | |
| 11 | 2011 | 179 | |
| 12 | 2011 | 303 | |
| 13 | 2011 | 99 | |
| 14 | 2011 | 102 | |
| 15 | 2010 | 62 | |
| 16 | 2010 | 334 | |
| 17 | 2009 | 34 | |
| 18 | 2009 | 75 | |
| 19 | 2008 | 72 | |
| 20 | Activity of the T-type calcium channel antagonist Mibefradil in pancreatic cancer xenografts | 2008 | 4 |
About N.V. Rajeshkumar
N.V. Rajeshkumar is a scholar working on Oncology, Cancer Research, Transplantation, Complementary and alternative medicine and Biotechnology, having authored 43 papers that have together received 4.3k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (27 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Cells and Metastasis (7 papers), Cancer, Hypoxia, and Metabolism (5 papers), Epigenetics and DNA Methylation (5 papers), RNA modifications and cancer (4 papers), Cancer Research and Treatments (3 papers) and DNA Repair Mechanisms (3 papers). The work is most often cited by research in Oncology (2.8k citations), Cancer Research (1.3k citations), Biotechnology (289 citations), Molecular Biology (1.9k citations) and Immunology (398 citations). N.V. Rajeshkumar has collaborated with scholars based in United States, Spain and Japan. Frequent co-authors include Manuel Hidalgo, Anirban Maitra, Anirban Maitra, Daniel A. Laheru, Daniel D. Von Hoff, Shinichi Yabuuchi, Elizabeth De Oliveira, Antonio Jimeno, Belén Rubio‐Viqueira and Ignacio Garrido‐Laguna. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Cancer Research, British Journal of Cancer, Integrative Cancer Therapies and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.